A PLACEBO-CONTROLLED, DOSE-ESCALATION STUDY TO ASSESS THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SINGLE AND MULTIPLE DOSES OF ISIS 703802, TARGETING ANGPTL3, ADMINISTERED SUBCUTANEOUSLY TO HEALTHY VOLUNTEERS WITH ELEVATED TRIGLYCERIDES AND SUBJECTS WITH FAMILIAL HYPERCHOLESTEROLEMIA

Registry ID

ISIS 703802-CS1

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

PFIZER CANADA ULC

Start date

2015-11-24

Last update

2015-10-29

Conditions

• FAMILIAL HYPERCHOLESTEROLEMIA

Related clinical trials

• PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ZODASIRAN IN ADOLESCENT AND ADULT SUBJECTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (YOSEMITE)
• AN OPEN-LABEL, SINGLE ARM, MULTICENTER EXTENSION STUDY TO EVALUATE LONG-TERM SAFETY AND TOLERABILITY OF INCLISIRAN IN PARTICIPANTS WITH HETEROZYGOUS OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WHO HAVE COMPLETED THE PEDIATRIC ORION-16, ORION-13, ORION-20, OR ORION-19 STUDIES (VICTORION-PEDS-OLE)

View on source registry